PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action
Open accessThe DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Abstract
The proliferator-activated receptor γ (PPARγ), a member of the nuclear receptor superfamily, is one of the most extensively studied ligand-inducible transcription factors. Since its identification in the early 1990s, PPARγ is best known for its critical role in adipocyte differentiation, maintenance, and function. Emerging evidence indicates that PPARγ is also important for the maturation and function of various immune system-related cell types, such as monocytes/macrophages, dendritic cells, and lymphocytes. Furthermore, PPARγ controls cell proliferation in various other tissues and organs, including colon, breast, prostate, and bladder, and dysregulation of PPARγ signaling is linked to tumor development in these organs. Recent studies have shed new light on PPARγ (dys)function in these three biological settings, showing unified and diverse mechanisms of action. Classical transactivation—where PPARγ activates genes upon binding to PPAR response elements as a heterodimer with RXRα—is important in all three settings, as underscored by natural loss-of-function mutations in FPLD3 and loss- and gain-of-function mutations in tumors. Transrepression—where PPARγ alters gene expression independent of DNA binding—is particularly relevant in immune cells. Interestingly, gene translocations resulting in fusion of PPARγ with other gene products, which are unique to specific carcinomas, present a third mode of action, as they potentially alter PPARγ’s target gene profile. Improved understanding of the molecular mechanism underlying PPARγ activity in the complex regulatory networks in metabolism, cancer, and inflammation may help to define novel potential therapeutic strategies for prevention and treatment of obesity, diabetes, or cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Wu, J., Boström, P., Sparks, L. M., Ye, L., Choi, J. H., Giang, A.-H., Khandekar, M., Virtanen, K. A., Nuutila, P., Schaart, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.016 · Cited by 3,319
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058
Comprehensive molecular characterization of urothelial bladder carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/za09-dk57 · Cited by 2,990
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
What we talk about when we talk about fat
Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373 · cited 1×
“Although these three type of adipocytes rise from different precursors and differ significantly in their morphology and function, the cells all go through a well-orchestrated differentiation process to become mature and fully functional (50).”
BackgroundmPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Eagle, A. R., Vats, D., Brombacher, F., Ferrante, A. W., et al. (2007) · Nature · doi:10.1038/nature05894 · Cited by 2,107 · cited 1×
“Next to macrophage and DC differentiation and macrophage polarization, PPARg can also directly regulate lipid metabolism in immune cells (37, 87, 92, 97, 98), reminiscent of its role in”
BackgroundFat and Beyond: The Diverse Biology of PPARγ
Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., & Milburn, M. V. (1998) · Nature · doi:10.1038/25931 · Cited by 1,958
Transcriptional regulation of adipogenesis
Rosen, E. D., Walkey, C. J., Puigserver, P., & Spiegelman, B. M. (2000) · Genes & Development · doi:10.1101/gad.14.11.1293 · Cited by 1,898
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
Yki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Choi, W., Porten, S., Kim, S., Willis, D., Plimack, E. R., Hoffman-Censits, J., Roth, B., Cheng, T., Tran, M., Lee, I.-L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.009 · Cited by 1,716
C/EBPα induces adipogenesis through PPARγ: a unified pathway
Rosen, E. D., Hsu, C.-H., Wang, X., Sakai, S., Freeman, M. W., Gonzalez, F. J., & Spiegelman, B. M. (2002) · Genes & Development · doi:10.1101/gad.948702 · Cited by 1,494
Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Barroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368 · cited 14×
“Mutations indicated above the PPARg structure are mutations are germline loss-of-function mutation, implicated in FPLD3.”
BackgroundInfluentialA PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
Chawla, A., Boisvert, W. A., Lee, C.-H., Laffitte, B. A., Barak, Y., Joseph, S. B., Liao, D., Nagy, L., Edwards, P. A., Curtiss, L. K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00164-2 · Cited by 1,347 · cited 2×
“Next to macrophage and DC differentiation and macrophage polarization, PPARg can also directly regulate lipid metabolism in immune cells (37, 87, 92, 97, 98), reminiscent of its role in”
BackgroundBouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.010 · Cited by 1,325
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254
Albert, M. L., Pearce, S. F. A., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., & Bhardwaj, N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1359 · Cited by 1,234
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A.-M., Saladin, R., Najib, J., Laville, M., Fruchart, J.-C., Deeb, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18779 · Cited by 1,188
Transcriptional Control of Brown Fat Determination by PRDM16
Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L. M., Uldry, M., Tavernier, G., Langin, D., & Spiegelman, B. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.001 · Cited by 1,174 · cited 1×
“org 7 De-acetylation of these residues is required for the recruitment of Prdm16, an essential cofactor in BAT (72).”
BackgroundChinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170 · cited 1×
“Next to macrophage and DC differentiation and macrophage polarization, PPARg can also directly regulate lipid metabolism in immune cells (37, 87, 92, 97, 98), reminiscent of its role in”
BackgroundPPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells
Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S. E., Benoist, C., & Mathis, D. (2012) · Nature · doi:10.1038/nature11132 · Cited by 1,143 · cited 3×
“Interestingly, the PPARg1 and PPARg2 isoforms induce the same genes upon activation in VAT Tregs (mainly related to lipid metabolism) but differ in the genes that they downregulate (6), the latter happening most likely through the mechanism of transrepression.”
BackgroundChawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., & Evans, R. M. (2001) · Nature Medicine · doi:10.1038/83336 · Cited by 1,069 · cited 2×
“Next to macrophage and DC differentiation and macrophage polarization, PPARg can also directly regulate lipid metabolism in immune cells (37, 87, 92, 97, 98), reminiscent of its role in”
BackgroundResultDifferentiation and reversal of malignant changes in colon cancer through PPARγ
Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., et al. (1998) · Nature Medicine · doi:10.1038/2030 · Cited by 988
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Choi, J. H., Banks, A. S., Estall, J. L., Kajimura, S., Boström, P., Laznik, D., Ruas, J. L., Chalmers, M. J., Kamenecka, T. M., Blüher, M., et al. (2010) · Nature · doi:10.1038/nature09291 · Cited by 875
Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
Huang, J. T., Welch, J. S., Ricote, M., Binder, C. J., Willson, T. M., Kelly, C., Witztum, J. L., Funk, C. D., Conrad, D., & Glass, C. K. (1999) · Nature · doi:10.1038/22572 · Cited by 855
Terminal Differentiation of Human Breast Cancer through PPARγ
Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., & Spiegelman, B. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80047-7 · Cited by 851
Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA
Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T. P., & Rastinejad, F. (2008) · Nature · doi:10.1038/nature07413 · Cited by 808 · cited 14×
“In this case, PPARg does not bind to DNA itself, and several studies indicate that PPARg transrepresses genes as a monomer, i.e., independent of RXRa (23).”
BackgroundInfluentialBrown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ
Qiang, L., Wang, L., Kon, N., Zhao, W., Lee, S., Zhang, Y., Rosenbaum, M., Zhao, Y., Gu, W., Farmer, S. R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.027 · Cited by 799
PAX8-PPAR γ 1 Fusion in Oncogene Human Thyroid Carcinoma
Kroll, T. G., Sarraf, P., Pecciarini, L., Chen, C.-J., Mueller, E., Spiegelman, B. M., & Fletcher, J. A. (2000) · Science · doi:10.1126/science.289.5483.1357 · Cited by 784
PPARγ agonists Induce a White-to-Brown Fat Conversion through Stabilization of PRDM16 Protein
Ohno, H., Shinoda, K., Spiegelman, B. M., & Kajimura, S. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.019 · Cited by 747
Ricote, M., Huang, J., Fajas, L., Li, A., Welch, J., Najib, J., Witztum, J. L., Auwerx, J., Palinski, W., & Glass, C. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7614 · Cited by 721
The biology of white adipocyte proliferation
Hausman, D. B., DiGirolamo, M., Bartness, T. J., Hausman, G. J., & Martin, R. J. (2001) · Obesity Reviews · doi:10.1046/j.1467-789x.2001.00042.x · Cited by 707
PPARγ and the global map of adipogenesis and beyond
Lefterova, M. I., Haakonsson, A. K., Lazar, M. A., & Mandrup, S. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.04.001 · Cited by 623
Schneider, C., Nobs, S. P., Kurrer, M., Rehrauer, H., Thiele, C., & Kopf, M. (2014) · Nature Immunology · doi:10.1038/ni.3005 · Cited by 614
Lefebvre, A.-M., Chen, I., Desreumaux, P., Najib, J., Fruchart, J.-C., Geboes, K., Briggs, M., Heyman, R., & Auwerx, J. (1998) · Nature Medicine · doi:10.1038/2036 · Cited by 611
Kubota, T., Koshizuka, K., Williamson, E. A., Asou, H., SAID, J. W., Holden, S. A., Miyoshi, I., & Koeffler, H. P. (1998) · PubMed · Cited by 589
Activators of the nuclear receptor PPARγ enhance colon polyp formation
Saez, E., Tontonoz, P., Nelson, M. C., Alvarez, J. G. A., U, T. M., Baird, S. M., Thomazy, V. A., & Evans, R. M. (1998) · Nature Medicine · doi:10.1038/2042 · Cited by 587
PPARs and molecular mechanisms of transrepression
Ricote, M., & Glass, C. K. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.013 · Cited by 570
White, Brown, Beige/Brite: Different Adipose Cells for Different Functions?
Giralt, M., & Villarroya, F. (2013) · Endocrinology · doi:10.1210/en.2013-1403 · Cited by 555
The Common and Distinct Features of Brown and Beige Adipocytes
Ikeda, K., Maretich, P., & Kajimura, S. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.01.001 · Cited by 543
The obese adipose tissue microenvironment in cancer development and progression
Quail, D. F., & Dannenberg, A. J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0126-x · Cited by 542
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
Choi, J. H., Banks, A. S., Kamenecka, T. M., Busby, S. A., Chalmers, M. J., Kumar, N., Kuruvilla, D. S., Shin, Y., He, Y., Bruning, J. B., et al. (2011) · Nature · doi:10.1038/nature10383 · Cited by 536
Nielsen, R., Pedersen, T. Å., Hagenbeek, D., Moulos, P., Siersbæk, R., Megens, E., Denissov, S., Børgesen, M., Francoijs, K.-J., Mandrup, S., et al. (2008) · Genes & Development · doi:10.1101/gad.501108 · Cited by 520
Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes
Soccio, R. E., Chen, E. R., & Lazar, M. A. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.005 · Cited by 518
The role of PPAR-γ in macrophage differentiation and cholesterol uptake
Moore, K. J., Rosen, E. D., Fitzgerald, M. L., Randow, F., Andersson, L. P., Altshuler, D., Milstone, D. S., Mortensen, R. M., Spiegelman, B. M., & Freeman, M. W. (2001) · Nature Medicine · doi:10.1038/83328 · Cited by 513
Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer
Sarraf, P., Mueller, E., Smith, W. M., Wright, H. M., Kum, J. B., Aaltonen, L. A., de la Chapelle, A., Spiegelman, B. M., & Eng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(01)80012-5 · Cited by 506
PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis
Macchia, P. E., Lapi, P., Krude, H., Pirro, M. T., Missero, C., Chiovato, L., Souabni, A., Baserga, M., Tassi, V., Pinchera, A., et al. (1998) · Nature Genetics · doi:10.1038/ng0598-83 · Cited by 501
Clark, R. B., Bishop-Bailey, D., Estrada-Hernandez, T., Hla, T., Puddington, L., & Padula, S. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1364 · Cited by 465
Szanto, A., Balint, B. L., Nagy, Z. S., Barta, E., Dezso, B., Pap, A., Szeles, L., Poliska, S., Oros, M., Evans, R. M., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.009 · Cited by 448
Welch, J. S., Ricote, M., Akiyama, T. E., Gonzalez, F. J., & Glass, C. K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031789100 · Cited by 429
Greene, M. E., Blumberg, B., McBride, O. W., Yi, H., Kronquist, K. E., Kwan, K. W., Hsieh, L., Greene, G. L., & Nimer, S. D. (1995) · Europe PMC (PubMed Central) · Cited by 399
Rebouissou, S., Bernard-Pierrot, I., de Reyniès, A., Lepage, M.-L., Krucker, C., Chapeaublanc, E., Hérault, A., Kamoun, A., Caillault, A., Letouzé, E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008970 · Cited by 386
Tontonoz, P., Graves, R. A., Budavari, A. I., Erdjument-Bromage, H., Lui, M., Hu, E., Tempst, P., & Spiegelman, B. M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.25.5628 · Cited by 383
Yang, X. Y., Wang, L. H., Chen, T., Hodge, D. R., Resau, J. H., DaSilva, L., & Farrar, W. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4541 · Cited by 377
Enerbäck, S. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.008 · Cited by 370
Adipocytes arise from multiple lineages that are heterogeneously and dynamically distributed
Sanchez-Gurmaches, J., & Guertin, D. A. (2014) · Nature Communications · doi:10.1038/ncomms5099 · Cited by 360
Klotz, L., Burgdorf, S., Dani, I., Saijo, K., Flossdorf, J., Hucke, S., Alferink, J., Novak, N., Beyer, M., Mayer, G., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082771 · Cited by 354
Adipocyte-derived endotrophin promotes malignant tumor progression
Park, J., & Scherer, P. E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63930 · Cited by 350
Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ
Bell-Parikh, L. C., Ide, T., Lawson, J. A., McNamara, P., Reilly, M., & FitzGerald, G. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18012 · Cited by 341
Kelly, I. E., Han, T. S., Walsh, K., & Lean, M. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.288 · Cited by 315
Tsubouchi, Y., Sano, H., Kawahito, Y., Mukai, S., Yamada, R., Kohno, M., Inoue, K.-I., Hla, T., & Kondo, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2436 · Cited by 315
Implications of nonshivering thermogenesis for energy balance regulation in humans
van Marken Lichtenbelt, W. D., & Schrauwen, P. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00652.2010 · Cited by 311
Le Naour, F., Hohenkirk, L., Grolleau, A., Misek, D. E., Lescure, P., Geiger, J. D., Hanash, S., & Beretta, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100156200 · Cited by 284
Madsen, M. S., Siersbæk, R., Boergesen, M., Nielsen, R., & Mandrup, S. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01344-13 · Cited by 272 · cited 1×
“The context-dependency of PPARg binding is at least in part mediated by cooperative binding to the chromatin with other adipogenic transcription factors, such as C/EBPa, followed by cooperative recruitment of coactivators (15).”
BackgroundIshay-Ronen, D., Diepenbruck, M., Kalathur, R. K. R., Sugiyama, N., Tiede, S., Ivanek, R., Bantug, G., Morini, M. F., Wang, J., Hess, C., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.12.002 · Cited by 270
Li, P., Fan, W., Xu, J., Lu, M., Yamamoto, H., Auwerx, J., Sears, D. D., Talukdar, S., Oh, D., Chen, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.050 · Cited by 266
Gosset, P., Charbonnier, A.-S., Delerive, P., Fontaine, J., Staels, B., Pestel, J., Tonnel, A., & Trottein, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<2857::aid-immu2857>3.0.co;2-x · Cited by 260
Pax8 has a key role in thyroid cell differentiation
Pasca di Magliano, M., Di Lauro, R., & Zannini, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240336397 · Cited by 256
Motomura, W., Okumura, T., Takahashi, N., OBARA, T., & Kohgo, Y. (2000) · PubMed · doi:10.11501/3186319 · Cited by 241
Mitochondria in White, Brown, and Beige Adipocytes
Cedikova, M., Kripnerová, M., Dvorakova, J., Pitule, P., Grundmanova, M., Babuska, V., Mullerova, D., & Kuncova, J. (2016) · Stem Cells International · doi:10.1155/2016/6067349 · Cited by 234
Nuclear receptors versus inflammation: mechanisms of transrepression
Pascual, G., & Glass, C. K. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.08.005 · Cited by 228
Review of the Structural and Dynamic Mechanisms of PPAR γ Partial Agonism
Kroker, A. J., & Bruning, J. B. (2015) · PPAR Research · doi:10.1155/2015/816856 · Cited by 217
Biton, A., Bernard-Pierrot, I., Lou, Y., Krucker, C., Chapeaublanc, E., Rubio-Pérez, C., López-Bigas, N., Kamoun, A., Neuzillet, Y., Gestraud, P., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.035 · Cited by 213
Lefterova, M. I., Steger, D. J., Zhuo, D., Qatanani, M., Mullican, S. E., Tuteja, G., Manduchi, E., Grant, G. R., & Lazar, M. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01651-09 · Cited by 207
Understanding nuclear receptor form and function using structural biology
Rastinejad, F., Huang, P., Chandra, V., & Khorasanizadeh, S. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0173 · Cited by 207
PPARγ in immunity and inflammation: cell types and diseases
Széles, L., Törőcsik, D., & Nagy, L. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.005 · Cited by 201
PPARγ in the control of brown adipocyte differentiation
Nedergaard, J., Petrovic, N., Lindgren, E. M., Jacobsson, A., & Cannon, B. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.02.003 · Cited by 200
Dendritic Cell Immunogenicity Is Regulated by Peroxisome Proliferator-Activated Receptor γ
Nencioni, A., Grünebach, F., Zobywlaski, A., Denzlinger, C., Brugger, W., & Brossart, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1228 · Cited by 200
An alternate binding site for PPARγ ligands
Hughes, T. S., Giri, P. K., de Vera, I. M. S., Marciano, D. P., Kuruvilla, D. S., Shin, Y., Blayo, A.-L., Kamenecka, T. M., Burris, T. P., Griffin, P. R., et al. (2014) · Nature Communications · doi:10.1038/ncomms4571 · Cited by 198 · cited 4×
“Furthermore, coregulatorbinding assays indicate that alternate site binding has an impact on coregulator interactions, transactivation, and target gene expression (49).”
BackgroundInfluentialSzatmari, I., Pap, A., Rühl, R., Ma, J.-X., Illarionov, P. A., Besra, G. S., Rajnavolgyi, E., Dezso, B., & Nagy, L. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060141 · Cited by 189
Detection of the PAX8-PPARγ Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas
Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., & Robinson, B. G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021020 · Cited by 188
Daniel, B., Nagy, G., Czimmerer, Z., Horvath, A., Hammers, D. W., Cuaranta-Monroy, I., Poliska, S., Tzerpos, P., Kolostyak, Z., Hays, T. T., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.005 · Cited by 178
The Nuclear Receptor PPARs as Important Regulators of T-Cell Functions and Autoimmune Diseases
Choi, J.-M., & Bothwell, A. L. M. (2012) · Molecules and Cells · doi:10.1007/s10059-012-2297-y · Cited by 176
Role of PPAR γ and EGFR signalling in the urothelial terminal differentiation programme
Varley, C. L., Stahlschmidt, J., Lee, W.-C., Holder, J., Diggle, C., Selby, P. J., Trejdosiewicz, L. K., & Southgate, J. (2004) · Journal of Cell Science · doi:10.1242/jcs.01042 · Cited by 175
Szatmári, I., Gogolák, P., Im, J. S., Dezsö, B., Rajnavölgyi, É., & Nagy, L. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.003 · Cited by 174
Efficacy of troglitazone on body fat distribution in type 2 diabetes.
Akazawa, S., Sun, F., Ito, M., Kawasaki, E., & Eguchi, K. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1067 · Cited by 171
Reversible transdifferentiation of secretory epithelial cells into adipocytes in the mammary gland
Morroni, M., Giordano, A., Zingaretti, M. C., Boiani, R., De Matteis, R., Kahn, B. B., Nisoli, E., Tonello, C., Pisoschi, C., Luchetti, M. M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407647101 · Cited by 170
Mayoral, R., Osborn, O., McNelis, J., Johnson, A. M., Oh, D. Y., Izquierdo, C. L., Chung, H., Li, P., Traves, P. G., Bandyopadhyay, G., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.02.007 · Cited by 169
Hontecillas, R., & Bassaganya-Riera, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2940 · Cited by 166
Tai, T.-A. C., Jennermann, C., Brown, K. K., Oliver, B. B., MacGinnitie, M. A., Wilkison, W. O., Brown, H. R., Lehmann, J. M., Kliewer, S. A., Morris, D. C., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29909 · Cited by 154
Nobs, S. P., Natali, S., Pohlmeier, L., Okreglicka, K., Schneider, C., Kurrer, M., Sallusto, F., & Kopf, M. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162069 · Cited by 154
Gallardo-Soler, A., Gómez-Nieto, C., Campo, M. L., Marathe, C., Tontonoz, P., Castrillo, A., & Corraliza, I. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0525 · Cited by 151
Transcriptional Inactivation of STAT3 by PPARγ Suppresses IL-6-Responsive Multiple Myeloma Cells
Wang, L. H., Yang, X. Y., Zhang, X., Huang, J., Hou, J., Li, J., Xiong, H., Mihalic, K., Zhu, H., Xiao, W., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00030-5 · Cited by 148
Posttranslational Modifications of PPAR‐γ: Fine‐tuning the Metabolic Master Regulator
van Beekum, O., Fleskens, V., & Kalkhoven, E. (2009) · Obesity · doi:10.1038/oby.2008.473 · Cited by 146
Self-citationPax-8–PPAR-γ fusion protein in thyroid carcinoma
Raman, P., & Koenig, R. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.115 · Cited by 144
Benzoyl 2-methyl indoles as selective PPARγ modulators
Acton, J. J., Black, R. M., Jones, A. B., Moller, D. E., Colwell, L. F., Doebber, T. W., MacNaul, K. L., Berger, J. P., & Wood, H. B. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.10.068 · Cited by 138
Reka, A. K., Kurapati, H., Narala, V. R., Bommer, G., Chen, J., Standiford, T. J., & Keshamouni, V. G. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0570 · Cited by 136
Kojetin, D. J., & Burris, T. P. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.079285 · Cited by 135
PPARγ regulates the function of human dendritic cells primarily by altering lipid metabolism
Szatmari, I., Töröcsik, D., Agostini, M., Nagy, T., Gurnell, M., Barta, E., Chatterjee, K., & Nagy, L. (2007) · Blood · doi:10.1182/blood-2007-06-096222 · Cited by 133
Synergy between PPARγ Ligands and Platinum-Based Drugs in Cancer
Girnun, G. D., Naseri, E., Vafai, S. B., Qu, L., Szwaya, J. D., Bronson, R. T., Alberta, J. A., & Spiegelman, B. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.025 · Cited by 128
Bren‐Mattison, Y., Putten, V. V., Chan, D. C. F., Winn, R. A., Geraci, M. W., & Nemenoff, R. A. (2004) · Oncogene · doi:10.1038/sj.onc.1208333 · Cited by 124
Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms
Hollman, D. A. A., Milona, A., van Erpecum, K. J., & van Mil, S. W. C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.004 · Cited by 124
Cinti, S. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.05.007 · Cited by 118
Siersbæk, M. S., Loft, A., Aagaard, M. M., Nielsen, R., Schmidt, S. F., Petrovic, N., Nedergaard, J., & Mandrup, S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00526-12 · Cited by 116
Park, J., Morley, T. S., & Scherer, P. E. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202006 · Cited by 111
Lasar, D., Rosenwald, M., Kiehlmann, E., Balaz, M., Tall, B., Opitz, L., Lidell, M. E., Zamboni, N., Krznar, P., Sun, W., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.067 · Cited by 111
Nakamura, T., Funahashi, T., Yamashita, S., Nishida, M., Nishida, Y., Takahashi, M., Hotta, K., Kuriyama, H., Kihara, S., Ohuchi, N., et al. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00319-9 · Cited by 110
Brown vs white adipocytes: The PPARγ coregulator story
Koppen, A., & Kalkhoven, E. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.06.035 · Cited by 109
Self-citationFunctional implications of genetic variation in human PPARγ
Jeninga, E. H., Gurnell, M., & Kalkhoven, E. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.04.005 · Cited by 109
Self-citationBrown adipose tissue in humans
Enerbäck, S. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.183 · Cited by 107
Regulation of Th17 Differentiation by Epidermal Fatty Acid-Binding Protein
Li, B., Reynolds, J. M., Stout, R. D., Bernlohr, D. A., & Suttles, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804192 · Cited by 101
Angeli, V., Hammad, H., Staels, B., Capron, M., Lambrecht, B. N., & Trottein, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5295 · Cited by 90
Halstead, A. M., Kapadia, C. D., Bolzenius, J. K., Chu, C. E., Schriefer, A. E., Wartman, L. D., Bowman, G. R., & Arora, V. K. (2017) · eLife · doi:10.7554/elife.30862 · Cited by 90
Recurrent activating mutations of PPARγ associated with luminal bladder tumors
Rochel, N., Krucker, C., Coutos-Thévenot, L., Ősz, J., Zhang, R., Guyon, E., Zita, W., Vanthong, S., Hernandez‐Alba, O., Bourguet, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08157-y · Cited by 90
Aprile, M., Cataldi, S., Ambrosio, M. R., D’Esposito, V., Lim, K., Dietrich, A., Blüher, M., Savage, D. B., Formisano, P., Ciccodicola, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.035 · Cited by 89
Bonofiglio, D., Cione, E., Qi, H., Pingitore, A., Perri, M., Catalano, S., Vizza, D., Panno, M. L., Genchi, G., Fuqua, S. A. W., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081078 · Cited by 85
Lui, W., Zeng, L., Rehrmann, V., Deshpande, S. S., Tretiakova, M., Kaplan, E. L., Leibiger, I. B., Leibiger, B., Enberg, U., Höög, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1085 · Cited by 85
Repression of IFN-γ Expression by Peroxisome Proliferator-Activated Receptor γ
Cunard, R., Eto, Y., Muljadi, J. T., Glass, C. K., Kelly, C. J., & Ricote, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7530 · Cited by 77
Nielsen, R., Grøntved, L., Stunnenberg, H. G., & Mandrup, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02266-05 · Cited by 77
Chung, S. W., Kang, B. Y., & Kim, T. S. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1169 · Cited by 76
Selective Modulators of PPAR Activity as New Therapeutic Tools in Metabolic Diseases
Balint, B., & Nagy, L. (2006) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153006776056620 · Cited by 74
Human endotrophin as a driver of malignant tumor growth
Bu, D., Crewe, C., Kusminski, C. M., Gordillo, R., Ghaben, A. L., Kim, M., Park, J., Deng, H., Xiong, W., Liu, X., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125094 · Cited by 71
Nuclear receptors in inflammation control: Repression by GR and beyond
Chinenov, Y., Gupte, R., & Rogatsky, I. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.006 · Cited by 61
Khandekar, M. J., Banks, A. S., Laznik-Bogoslavski, D., White, J. P., Choi, J. H., Kazak, L., Lo, J. C., Cohen, P., Wong, K., Kamenecka, T. M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717776115 · Cited by 60
Le Menn, G., & Neels, J. G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061575 · Cited by 60
Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells
Ninomiya, I., Yamazaki, K., Oyama, K., Hayashi, H., Tajima, H., Kitagawa, H., Fushida, S., Fujimura, T., & Ohta, T. (2014) · Oncology Letters · doi:10.3892/ol.2014.2553 · Cited by 59
Peroxisome Proliferator-activated Receptor γ-mediated Differentiation
Gupta, R. A., Sarraf, P., Mueller, E., Brockman, J. A., Prusakiewicz, J. J., Eng, C., Willson, T. M., & DuBois, R. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300637200 · Cited by 59
The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases
Park, B. V., & Pan, F. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.21 · Cited by 52
Jeninga, E. H., van Beekum, O., van Dijk, A. D. J., Hamers, N., Hendriks-Stegeman, B. I., Bonvin, A. M. J. J., Berger, R., & Kalkhoven, E. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0485 · Cited by 52
Self-citationBroekema, M. F., Savage, D. B., Monajemi, H., & Kalkhoven, E. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.02.002 · Cited by 48
Self-citationBoos, L. A., Dettmer, M. S., Schmitt, A. M., Rudolph, T. J., Steinert, H. C., Moch, H., Sobrinho-Simões, M. A., Komminoth, P., & Perren, A. A. (2013) · Histopathology · doi:10.1111/his.12150 · Cited by 44
Sun, K., Park, J., Kim, M., & Scherer, P. E. (2017) · Diabetologia · doi:10.1007/s00125-016-4130-1 · Cited by 44
Mercer, S. W., & Trayhurn, P. (1986) · FEBS Letters · doi:10.1016/0014-5793(86)80120-x · Cited by 36
PPARγ sumoylation-mediated lipid accumulation in lung cancer
Phan, A. N. H., Vo, V. T. A., Hua, T. N. M., Kim, M.-K., Jo, S., Choi, J.-W., Kim, H.-W., Son, J., Suh, Y., & Jeong, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.19700 · Cited by 26
Ceni, E., Mello, T., Tarocchi, M., Crabb, D.-W., Caldini, A. L., Invernizzi, P., Surrenti, C., Milani, S., & Galli, A. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i8.1122 · Cited by 25
Ciglitazone is not itself thermogenic but increases the potential for thermogenesis in lean mice
Thurlby, P. L., Wilson, S., & Arch, J. R. S. (1987) · Bioscience Reports · doi:10.1007/bf01119774 · Cited by 24
Natural helix 9 mutants of PPARγ differently affect its transcriptional activity
Broekema, M. F., Massink, M. P. G., Donato, C., de Ligt, J., Schaarschmidt, J., Borgman, A., Schooneman, M. G., Melchers, D., Gerding, M. N., Houtman, R., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.12.005 · Cited by 24
Self-citationZhang, Y., Yu, J., Grachtchouk, V., Qin, T., Lumeng, C. N.-K., Sartor, M. A., & Koenig, R. J. (2016) · Oncotarget · doi:10.18632/oncotarget.14050 · Cited by 19
Perakakis, N., Joshi, A., Peradze, N., Stefanakis, K., Li, G., Feigh, M., Veidal, S. S., Rosen, G., Fleming, M., & Mantzoros, C. S. (2020) · Hepatology Communications · doi:10.1002/hep4.1558 · Cited by 19
Cuaranta‐Monroy, I., Kiss, M., Simándi, Z., & Nagy, L. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12491 · Cited by 16
PPARγ is a tumor suppressor in basal bladder tumors offering new potential therapeutic opportunitiesPreprint
Coutos-Thévenot, L., Beji, S., Neyret‐Kahn, H., Pippo, Q., Fontugne, J., Ősz, J., Krucker, C., Groeneveld, C. S., Dufour, F., Kamoun, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/868190 · Cited by 9
Electrical Neurostimulation Promotes Brown Adipose Tissue Thermogenesis
Zhuang, L., de Jonge, W. J., Wang, Y., Rensen, P. C. N., & Kooijman, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.567545 · Cited by 6
The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases
Park, B. V., & Pan, F. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.021 · Cited by 2
Cited by
The mechanism of HMGB1 secretion and release
Chen, R., Kang, R., & Tang, D. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00736-w · Cited by 849
Inflammation in atherosclerosis: pathophysiology and mechanisms
Ajoolabady, A., Pratico, D., Lin, L., Mantzoros, C. S., Bahijri, S., Tuomilehto, J., & Ren, J. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-07166-8 · Cited by 447
Hodgkinson, K., El Abbar, F., Dobranowski, P., Manoogian, J., Butcher, J., Figeys, D., Mack, D., & Stintzi, A. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2022.10.024 · Cited by 423
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Cunningham, R., & Hansen, C. G. (2022) · Clinical Science · doi:10.1042/cs20201474 · Cited by 326
MMP10 alleviates non-alcoholic steatohepatitis by regulating macrophage M2 polarization
Chang, L., Gao, J., Yu, Y., Liao, B., Zhou, Y., Zhang, J., Ma, X., Hou, W., Zhou, T., & Xu, Q. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111045 · Cited by 20
Metadata
- Authors
- Hernandez-Quiles, M., Broekema, M. F., & Kalkhoven, E.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2021-02-26
- Volume
- 12
- Pages
- 624112-624112
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W3133116384
- Cited by
- 433
- References
- 157
- FWCI
- 17.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.